HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Tang Selected Research

hexamethylene bisacetamide (HMBA)

12/2010Localization and altered expression of nucleophosmin in the nuclear matrix during the differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA.
8/2008Positional and expressive alteration of prohibitin during the induced differentiation of human hepatocarcinoma SMMC-7721 cells.
7/2008[Expression and localization of hnRNP A2/B1 during differentiation of human osteosarcoma MG-63 cells induced by HMBA].
2/2008[Localization of prohibitin in nuclear matrix and its expressive alteration during the differentiation of human osteosarcoma MG-63 cells induced by HMBA].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Tang Research Topics

Disease

52Neoplasms (Cancer)
03/2022 - 09/2003
15Inflammation (Inflammations)
01/2022 - 03/2005
12Neoplasm Metastasis (Metastasis)
11/2021 - 03/2005
11Crohn Disease (Crohn's Disease)
04/2022 - 03/2015
10Infections
08/2022 - 01/2013
8COVID-19
11/2021 - 05/2020
7Lung Neoplasms (Lung Cancer)
12/2020 - 11/2009
7Osteosarcoma (Osteogenic Sarcoma)
10/2019 - 01/2008
6Carcinogenesis
01/2022 - 09/2013
6Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 09/2013
5Ischemia
02/2022 - 04/2020
5Reperfusion Injury
02/2022 - 01/2016
5Glioma (Gliomas)
01/2022 - 10/2020
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2014
5Carcinoma (Carcinomatosis)
10/2021 - 08/2002
4Cicatrix (Scar)
01/2022 - 01/2016
4Pneumonia (Pneumonitis)
08/2020 - 05/2019
4Hypoxia (Hypoxemia)
01/2019 - 07/2014
3Ulcerative Colitis
12/2022 - 01/2022
3Necrosis
08/2022 - 01/2022
3Melanoma (Melanoma, Malignant)
03/2022 - 09/2021
3Fibrosis (Cirrhosis)
01/2022 - 01/2016
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 05/2017
3Adenocarcinoma
11/2020 - 12/2017
3Pituitary Neoplasms (Pituitary Adenoma)
08/2019 - 01/2015
3Esophageal Stenosis (Esophageal Stricture)
01/2019 - 01/2016
3Colorectal Neoplasms (Colorectal Cancer)
11/2018 - 01/2014
3Edema (Dropsy)
11/2018 - 03/2006
2Hematoma
08/2022 - 11/2008
2Type 2 Diabetes Mellitus (MODY)
08/2022 - 08/2020
2Neuroinflammatory Diseases
08/2022 - 01/2018
2Cognitive Dysfunction
08/2022 - 01/2022
2Pain (Aches)
01/2022 - 05/2017
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 06/2018
2Disease Progression
01/2022 - 01/2021
2Wounds and Injuries (Trauma)
12/2021 - 04/2018
2Brain Diseases (Brain Disorder)
09/2021 - 04/2021
2Cough
09/2021 - 04/2021
2Respiratory Sounds (Crackle)
09/2021 - 04/2021
2Thrombosis (Thrombus)
07/2021 - 05/2021
2Esophageal Squamous Cell Carcinoma
07/2021 - 01/2020
2Stomach Neoplasms (Stomach Cancer)
07/2021 - 01/2017
2Critical Illness (Critically Ill)
05/2021 - 01/2012
2Pathologic Constriction (Stenosis)
01/2021 - 01/2016
2Cardiac Arrhythmias (Arrythmia)
01/2021 - 08/2020
2Atrophy
01/2021 - 04/2006
2Sepsis (Septicemia)
01/2021 - 11/2018

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
03/2022 - 11/2003
14MicroRNAs (MicroRNA)IBA
12/2021 - 01/2012
11Pharmaceutical PreparationsIBA
01/2022 - 01/2008
10Messenger RNA (mRNA)IBA
12/2021 - 11/2008
8Therapeutic UsesIBA
11/2021 - 09/2003
7CytokinesIBA
01/2022 - 03/2014
6Long Noncoding RNAIBA
01/2022 - 04/2019
6Biological ProductsIBA
11/2020 - 11/2006
5VaccinesIBA
11/2021 - 01/2015
5Biomarkers (Surrogate Marker)IBA
10/2021 - 03/2015
5Polysaccharides (Glycans)IBA
05/2021 - 11/2006
4Interleukin-6 (Interleukin 6)IBA
08/2022 - 01/2017
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 01/2011
4Infliximab (Remicade)FDA Link
10/2021 - 10/2019
4Anti-Bacterial Agents (Antibiotics)IBA
08/2020 - 04/2011
4hexamethylene bisacetamide (HMBA)IBA
12/2010 - 02/2008
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2022 - 07/2020
3Mesalamine (Mesalazine)FDA LinkGeneric
12/2022 - 10/2021
3LipidsIBA
08/2022 - 11/2007
3Malondialdehyde (Propanedial)IBA
08/2022 - 06/2013
3AntioxidantsIBA
08/2022 - 06/2018
3Peptides (Polypeptides)IBA
04/2022 - 03/2003
32-mercaptopurineIBA
04/2022 - 10/2019
3AmylasesFDA Link
01/2022 - 04/2021
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2003
3Circular RNAIBA
12/2021 - 01/2019
3RNA (Ribonucleic Acid)IBA
10/2021 - 08/2020
3ProhibitinsIBA
11/2009 - 02/2008
2NF-kappa B (NF-kB)IBA
08/2022 - 01/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 12/2003
2Imiquimod (Aldara)FDA LinkGeneric
01/2022 - 06/2018
2Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 01/2021
2CateninsIBA
12/2021 - 07/2019
2Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 01/2011
2EnzymesIBA
01/2021 - 01/2015
2Beclin-1IBA
01/2021 - 01/2017
2Phenobarbital (Luminal)FDA Link
01/2021 - 11/2003
2Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2020
2Immune Checkpoint InhibitorsIBA
01/2021 - 12/2020
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2014

Therapy/Procedure

22Therapeutics
04/2022 - 11/2009
6Drug Therapy (Chemotherapy)
12/2020 - 11/2009
5Transplantation
03/2021 - 01/2012
4Immunotherapy
03/2022 - 10/2019
4Aftercare (After-Treatment)
03/2017 - 04/2006
3Lasers (Laser)
01/2022 - 02/2008
3Laminectomy
01/2022 - 01/2016
3Punctures
05/2021 - 01/2014
2Length of Stay
08/2022 - 11/2018
2Electroacupuncture
02/2022 - 03/2017
2Photochemotherapy (Photodynamic Therapy)
01/2022 - 07/2007
2Precision Medicine
01/2022 - 12/2020
2Surgical Instruments (Clip)
01/2021 - 12/2018